Skip to search formSkip to main contentSkip to account menu

ICI 170809

Known as: 2-Propanamine, N,N,2-trimethyl-1-((3-phenyl-2-quinolinyl)thio)-, ICI-170,809 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Quinolines
ZM 170809

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Platelet Ihydroxytryptamine is decreased in a preliminary group of depressed patients receiving the Ihydroxytryptamine reuptake inhi biting drug fluoxetine
1. In view of the importance of 5-hydroxytryptamine in coronary thrombosis, we wanted to know whether a potentially protective… 
1996
1996
Platelet 5-hydroxytryptamine is decreased in a preliminary group of depressed patients receiving the 5-hydroxytryptamine re-uptake inhibiting drug fluoxetine.
1. In view of the importance of 5-hydroxytryptamine in coronary thrombosis, we wanted to know whether a potentially protective… 
1993
1993
Effects of chronic treatment with two selective 5-HT2 antagonists on sleep in the rat
Highly Cited
1990
Highly Cited
1990
Behavioural effects of serotonin agonists and antagonists in the rat and marmoset
1990
1990
ICI 170809, A selective 5-hydroxytryptamine antagonist, inhibits human platelet aggregation in vitro and ex vivo
In vitro 5-hydroxytryptamine (5-HT) cause both a shape and aggregation of human platelets. Few studies have been reported on 5-HT… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)